HAIRY CELL LEUKEMIA VARIANT

Clinical trials for HAIRY CELL LEUKEMIA VARIANT explained in plain language.

Never miss a new study

Get alerted when new HAIRY CELL LEUKEMIA VARIANT trials appear

Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First-of-its-Kind immune cell therapy trial launches for Tough-to-Treat blood cancer

Disease control Recruiting now

This study is testing the safety and early effects of a new treatment called anti-CD22 CAR T-cell therapy for adults with hairy cell leukemia that has come back or not responded to other standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab …

Matched conditions: HAIRY CELL LEUKEMIA VARIANT

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

HAIRY CELL LEUKEMIA VARIANT

Get alerted when new HAIRY CELL LEUKEMIA VARIANT trials appear

First-of-its-Kind immune cell therapy trial launches for Tough-to-Treat blood cancer